RELATED CONTENT
News | Prostate Cancer
March 28, 2025 — Novartis has announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu ...
March 31, 2025 
News | Nuclear Imaging
May 9, 2022 — Novartis announced a temporary, voluntary suspension of production at its radioligand therapy production ...
May 09, 2022 